Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's painfully obvious how the 13Ders are saying and doing anything they can, including name calling and throwing spitballs at longs, to keep the share price down until after the proxy vote. They know that if CytoDyn is successful with launching the Brazil trials, they end up losing the vote. Their attempt to make it more difficult to fund the trials with minimal dilution shows how little they care about the patients who desperately need LL (unless it's for a close family member) - pure greed and manipulation, and nothing less.
Shorts and 13D scumbags working together so closely you can't tell the difference.
What?? Perhaps the 13D candidates wouldn't spend money protecting the shareholders from a hostile takeover attempt, but this CEO WILL protect the shareholders and it has nothing to do with "confidence". A responsible CEO wouldn't just roll over and not defend the company from a misfit band of marauders who have already attempted to steal the patent for LL after their failed attempt to steal $350m from the shareholders by charging an exorbitant amount for a tiny kit making company. I guess they saw how easy it was for Pestell to sell ProstaGene for millions after Tony C. let down the shareholders by doing a miserable job of completing the due diligence prior to the purchase. When is Pestell going to return his shares for selling us a worthless company?
Some here want to give Ken credit for acquiring PRO-140 after he resigned, yet they don't want to credit Tony C. with the deal he made for ProstaGene with his good buddy, Pestell. Unreal...
And btw, there WILL be a "vote"... but the 13D marauders won't be on the list of candidates.
IF THERE WAS ANY CONFIDENCE, WHY SPEND MILLIONS PREVENTING A VOTE?
It's funny how the 13Disaster crew sounds like they're getting nervous and trying to convince themselves that everything will be okay come Thurs morning. I've already placed my bets!
Yes, come Wed at 4:00, there's a good chance his popularity will take off like SpaceX - 13D's worst nightmare. Buy your tickets now while you can still afford them.
Is Nader Pourhassan a flight risk?
He bounced a $100 check in college. If you have proof otherwise, please feel free to share it.
No one gets a felony for a simple $100 overdraft.
He didn't get a felony for sending an email to his child. He most likely violated a restraining order filed against him by his now ex-wife.
You just told me you were on the fairway. Are you posting between swings?
You ask for someone to post 5 achievements but then disqualify several of his achievements. It's a good thing you didn't ask for Tony C's achievements or Pestell's achievements, because there wouldn't be any to disqualify.
I will stop posting here and on twitter if any Nada supporter can just list 5 "achievements"
What "crime" are you referring to?? Specifics - nothing general please.
"If you can't do the time, Don't do the crime."
Thank you for underscoring and proving Buddyboy's point! Please continue...
Actually, people have been asking for "months" and all we hear are crickets.
People have been asking for weeks, "what's the plan?"
Seriously?? Yes, it's very easy to find out because I just shared the dates and links in my post. All you need to do is read it or click on the links with your mouse.
When was the deal signed?
When did Nader become CEO?
Very easy to find out
Go back and read my other post where I clearly said: "Ken may have signed the initial papers with the intent to acquire it, but clearly wasn't in the drivers seat throughout the actual acquisition." You're confusing a purchase agreement with the actual acquisition. Anyone who works at an executive level knows the CEO isn't responsible for identifying new opportunities. The head of Business Development, in this case Nader, is the one who clearly identified PRO 140 as the path forward for the company, and the CEO agreed by signing the purchase agreement and then stepping down to allow Nader to fill his role. After all, as 3X said, Ken's expertise was Real Estate. I know it's painful for the 13Der's to admit this, but they cannot revise 9 years of history, especially when everyone already knows how and who rescued PRO 140 from the shelf. Prior to the 13D filing, NOBODY claimed it was Ken. If Ken had identified PRO 140 as the future, he wouldn't have signed the purchase agreement and then immediately stepped down so the Board could replace him with Nader to drive the acquisition and move the ball forward. That's laughable.
"You said Ken was CEO and deserved credit for rescuing PRO-140 from the shelf, yet it was Nader who was CEO when it was acquired. Now Ken may have signed the initial papers with the intent to acquire it, but clearly wasn't in the drivers seat throughout the actual acquisition. Additionally, as you mentioned below, Ken's area of expertise was real estate, which explains why he stepped down to let to Nader take the lead, especially given that Nader was the Managing Director of "Business Development" and obviously who would have been responsible for new business initiatives. As you should know, CEO's hire good business development talent who are are responsible for identifying new opportunities, and the CEOs normally follow their lead.
Sept 11, 2012 - CytoDyn Inc. Names Dr. Nader Pourhassan New CEO
https://investorshub.advfn.com/secure/post_reply.aspx?message_id=165779555
"Prior to his new position as CEO, Dr. Pourhassan served as the Company’s Managing Director of Business Development, and before that, as its Chief Operating Officer."
Oct 18, 2012 - CytoDyn Announces Acquisition of Pro 140
https://www.fiercepharma.com/pharma/cytodyn-announces-acquisition-of-pro-140
“CytoDyn is a company focused on the development of monoclonal antibodies for the treatment of immune deficiency viruses. Pro 140 is the most advanced cell-specific monoclonal antibody to date being tested for the treatment of HIV. This makes it a perfect fit for our company. We believe that Pro 140 represents an entirely new approach to treating HIV. We are excited about taking it forward through the next stages of clinical development,” said Dr. Nader Pourhassan, CytoDyn’s interim President and CEO."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165780498
so this document is bogus--got it
Read the Judge's orders again. "Slapping" them is putting it mildly. The 13D gang screwed up again.
Is it true the 13D gang scheduled their investors call for Monday, Labor Day? Unbelievable! Who does that?? Who is overseeing these constant screw ups? And they want to takeover CytoDyn?? Can you imagine these misfits trying to file a BLA for two Brazilian covid trials? Or a NASH trial?? Or a long haulers trial knowing the FDA has already warned people to not take the same drug Bruce is currently peddling to long hauler patients? I'm sure the FDA will never see that coming. Yikes!!!
The judge did not do anything of the sort in “slapping” them.
$500,000,000 in debts??? How did you come up with THAT number??? Half a billion dollars?? Why not go for half a trillion??
You have to be joking. What legitimate company is going to want to buy out or partner with a company that has over $500,000,000 in debts.
Bring on Bruce Patterson who is making a lot of headway in treating longhaulers.
Ken, the real estate guy per your description, moved on before the acquisition and therefore gets the credit. The Director of Business Development who rescued PRO 140 from the shelf and drove the purchase through the acquisition as the CEO and has been credited for saving it from the scrap heap for the last 9 years suddenly gets no credit. Got it
You said Ken was CEO and deserved credit for rescuing PRO-140 from the shelf, yet it was Nader who was CEO when it was acquired. Now Ken may have signed the initial papers with the intent to acquire it, but clearly wasn't in the drivers seat throughout the actual acquisition. Additionally, as you mentioned below, Ken's area of expertise was real estate, which explains why he stepped down to let to Nader take the lead, especially given that Nader was the Managing Director of "Business Development" and obviously who would have been responsible for new business initiatives. As you should know, CEO's hire good business development talent who are are responsible for identifying new opportunities, and the CEOs normally follow their lead.
Sept 11, 2012 - CytoDyn Inc. Names Dr. Nader Pourhassan New CEO
https://investorshub.advfn.com/secure/post_reply.aspx?message_id=165779555
"Prior to his new position as CEO, Dr. Pourhassan served as the Company’s Managing Director of Business Development, and before that, as its Chief Operating Officer."
Oct 18, 2012 - CytoDyn Announces Acquisition of Pro 140
https://www.fiercepharma.com/pharma/cytodyn-announces-acquisition-of-pro-140
“CytoDyn is a company focused on the development of monoclonal antibodies for the treatment of immune deficiency viruses. Pro 140 is the most advanced cell-specific monoclonal antibody to date being tested for the treatment of HIV. This makes it a perfect fit for our company. We believe that Pro 140 represents an entirely new approach to treating HIV. We are excited about taking it forward through the next stages of clinical development,” said Dr. Nader Pourhassan, CytoDyn’s interim President and CEO.
I can’t answer why Ken stepped down. I know he had other projects he was working on that were closer to his area of expertise ( real estate). Perhaps he felt the company was on the right track with his acquisition of Pro 140 and felt it was time to move on.
When did we get an EUA???
Now cydy is ending HIV meds and EUA and EIND--for costs
.
.
Meanwhile other covid drugs step up and have links on their websites to help people with EUA and right to try.
Because the patent has already been awarded to CytoDyn by the U.S. Patent Office. Bruce's application was denied for obvious reasons.
Than why doesn’t Bruce take it to court probably be a lot easier than jumping in with the 13d stooges
"Tried" to patent. LOL Right...and that's why the U.S. Patent Office gave the patent to CytoDyn. Got it!
Cytodyn tried to patent something Bruce created/discovered
Okay, let's make this easier. Given that NOBODY can give me one, just one, achievement of Tony C's while he was at CytoDyn for SEVEN YEARS, then just give me ONE of Pestell's achievements while he was at CytoDyn. Ripping off the shareholders by selling CytoDyn a worthless company doesn't count.
Are you looking for a copy of his patent application, or just the rejection from the U.S. Patent Office showing where he couldn't be given a patent that belongs to CytoDyn. They're easily found online. Everyone, well almost everyone, has seen them.
Show me a fact not an allegation.
No need to deflect because I've been asking this question for over a month now and NOBODY can give me one, just one, achievement of Tony C's while he was at CytoDyn, AND HE WAS THERE FOR SEVEN YEARS. Why is that???
So are you saying you would not support BP if the 13D coup was successful? (it won't be)
Anyone supporting a CEO that steals from them has the bigger issue on business acumen.
I'm still waiting for someone to lay out the achievements of Tony C. All I hear are crickets. But if you want some more achievements of Nader's, feel free to join the call on Wed.
BTW, did the 13D gang really schedule their call to discuss "the plan" on Monday, Labor Day?? Surely they didn't screw that up, too.
Lay out achievements as CEO.
And this is why the 13Disaster gang has NO chance of pushing thru the same director nominee who's accused of attempting to steal patents from CytoDyn.
I am confident most shareholders do not want a guy constantly stealing from them
CytoDyn isn't being investigated either given that NOBODY can produce any evidence that THEY are the targets of the investigations, especially given THEY are the ones who received the subpoenas. Are you familiar with those? If not, they are requests for information that may help support the facts that are at issue in a pending case, and normally given to witnesses.
As an example, let's assume one of the 13Ders had 888,888 thousand shares and accumulated them by flipping shares based off of inside information that he got from one of the proposed 13D director nominees while he was employed by CytoDyn. That would be grounds for a DOJ investigation, and that person would NOT receive a subpoena.
maybe because they aren’t being investigated by the Doj and sec for securities fraud and violations?
Why would Nader take advice from a group of buffoons who can't file a simple shareholder solicitation without screwing it up? And after their attorney, Rosenbomb, reviewed it. Laughable...
The Investor Group has previously reached out to Nader and BOD, only to be rebuffed.
I wouldn't rely on Madame Cleo for this.
Brazil has NOT started
All trials to date are failures
There’s no money
LOL
The 13D filing had no errors.
What has the 13D gang done right? They even mucked up the original 13D filing that had over 55 errors and missing forms. I wouldn't be surprised if the next filing is a class-action lawsuit from those who were misled into financially supporting the 13Disaster and demanding Rosenbomb return their contributions.
How much worse can it get for 13D..? Horrible management, hand smacked by SEC, and flipping shares for self enrichment. Yikes!! Double yikes!!
Federal judge finds CytoDyn 13D group did not comply with SEC rules
* A federal court judge found that a shareholder group trying to get five new members on the CytoDyn (OTCQB:CYDY) board violated SEC rules in that solicitations to shareholders weren't filed with the agency.
* The judge ordered that the group comply with federal securities laws and SEC rules.
In a news release, CytoDyn's board said the group was "caught red-handed" and has ignored transparency and mislead shareholders. "Shareholders should be highly concerned by this pattern of transgressions on the part of the Activist Group – which we believe underscores the Activist Group’s and its nominee’s lack of fitness to be entrusted with control of CytoDyn and our potentially lifesaving therapeutic drug candidate, leronlimab," the board added.
https://seekingalpha.com/news/3737147-federal-judge-finds-cytodyn-shareholder-group-did-not-comply-with-sec-rules?mail_subject=cydy-federal-judge-finds-cytodyn-shareholder-group-did-not-comply-with-sec-rules&utm_campaign=rta-stock-news&utm_content=link-1&utm_medium=email&utm_source=seeking_alpha
Speaking of the Vyera call that lit the fuse for the rapid sp increase from $.30 to $10, are you planning to sell 70% of your shares again before next Wed's conf call? Are you also predicting the sp will close in the red today?
the joke Vyera call
He does? Where can I find his posts?
Unlike former employees like Tony C. who accomplished nothing, or Pestell who spent most of his time there jetting around the world for speaking engagements while showing off his trophy wife, it's glaringly obvious NP doesn't have the time to goof off like them given everything that he's focused on like the two Brazil trials, HIV BLA, Nash trial interim results, etc.
Do you see Nader posting on message boards?
Yes, someone who runs a business and sits in a boardroom doesn't have time to be post all day. That's the downside of running a successful company.
It’s obvious that some have never run a business or sat in a boardroom
How does "see what was done" prove "The Brazil Trial is a long way from execution"??? Because it hasn't started proves it's a long way from execution?? LOL
yes,it,is…see what was done.
The The Brazil Trial is a long way from execution
Any day now! lol
Closer to $.75 every day.
Closed up another 3% today. So that make 7% yesterday and today? Seems to be headed in the opposite direction.
I’m looking to get back in at $.10
He's tweeting again, therefore the DOJ wasn't looking into him?? LOL
Also should be noted Adam Feuerstein is back tweeting again. So I guess the DOJ wasn't looking into him